Profadol, with the CAS number 428-37-5, is a synthetic opioid analgesic that exhibits properties similar to other opioids, such as morphine. It is primarily characterized by its ability to bind to the mu-opioid receptors in the central nervous system, leading to pain relief and sedation. Profadol is known for its analgesic effects, making it useful in medical settings for managing moderate to severe pain. However, like other opioids, it carries a risk of dependence, tolerance, and potential for abuse. Its pharmacological profile includes a relatively rapid onset of action, although the duration of its effects can vary. Additionally, profadol may produce side effects commonly associated with opioids, such as respiratory depression, constipation, and drowsiness. Due to its potential for misuse and the associated health risks, profadol is typically regulated under controlled substances legislation in many jurisdictions. As with any opioid, careful consideration of dosage and patient monitoring is essential to minimize adverse effects and ensure safe use.

profadol

428-37-5: Profadol, with the CAS number 428-37-5, is a synthetic opioid analgesic that exhibits properties similar to other opioids, such as morphine. It is primarily characterized by its ability to bind to the mu-opioid receptors in the central nervous system, leading to pain relief and sedation. Profadol is known for its analgesic effects, making it useful in medical settings for managing moderate to severe pain. However, like other opioids, it carries a risk of dependence, tolerance, and potential for abuse. Its pharmacological profile includes a relatively rapid onset of action, although the duration of its effects can vary. Additionally, profadol may produce side effects commonly associated with opioids, such as respiratory depression, constipation, and drowsiness. Due to its potential for misuse and the associated health risks, profadol is typically regulated under controlled substances legislation in many jurisdictions. As with any opioid, careful consideration of dosage and patient monitoring is essential to minimize adverse effects and ensure safe use.

CAS 428-37-5

profadol